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Abstract
Background: MicroRNAs (miRs) negatively regulate transcription and are important determinants of normal heart
development and heart failure pathogenesis. Despite the significant knowledge gained in mouse studies, their functional
roles in human (h) heart remain elusive.
Methods and Results: We hypothesized that miRs that figure prominently in cardiac differentiation are differentially
expressed in differentiating, developing, and terminally mature human cardiomyocytes (CMs). As a first step, we mapped
the miR profiles of human (h) embryonic stem cells (ESCs), hESC-derived (hE), fetal (hF) and adult (hA) ventricular (V) CMs. 63
miRs were differentially expressed between hESCs and hE-VCMs. Of these, 29, including the miR-302 and -371/372/373
clusters, were associated with pluripotency and uniquely expressed in hESCs. Of the remaining miRs differentially expressed
in hE-VCMs, 23 continued to express highly in hF- and hA-VCMs, with miR-1, -133, and -499 displaying the largest fold
differences; others such as miR-let-7a, -let-7b, -26b, -125a and -143 were non-cardiac specific. Functionally, LV-miR-499
transduction of hESC-derived cardiovascular progenitors significantly increased the yield of hE-VCMs (to 72% from 48% of
control; p,0.05) and contractile protein expression without affecting their electrophysiological properties (p.0.05). By
contrast, LV-miR-1 transduction did not bias the yield (p.0.05) but decreased APD and hyperpolarized RMP/MDP in hE-
VCMs due to increased Ito,I Ks and IKr, and decreased If (p,0.05) as signs of functional maturation. Also, LV-miR-1 but not -
499 augmented the immature Ca
2+ transient amplitude and kinetics. Molecular pathway analyses were performed for
further insights.
Conclusion: We conclude that miR-1 and -499 play differential roles in cardiac differentiation of hESCs in a context-
dependent fashion. While miR-499 promotes ventricular specification of hESCs, miR-1 serves to facilitate electrophysio-
logical maturation.
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Introduction
MicroRNAs (miRs) are non-encoding RNAs of ,22 nucleotides
that function as negative transcriptional regulators via degradation
or inhibition by RNA interference [1,2]. To date, 706 human
miRs have been identified, of which approximately 50% of pre-
miR sequences are located within introns according to the Sanger
Database. In mouse models, several miRs have been implicated in
normal cardiovascular development (e.g., miR-1, 18b, 20b, 21,
106a, 126, 133, 138, and 208) [3–8]. For instance, a 50% decrease
in total miR-1 results in embryonic death attributable to
ventricular septal defects and cardiac dysfunction [5]; whereas,
miR-1 over-expression in adult murine ventricular (V) cardiomy-
ocytes (CMs) promotes arrhythmogenesis by slowing conduction
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27417and depolarizing the sarcolemmal membrane via post-transcrip-
tional repression of the Kir2.1-encoded inwardly rectifying current
(IK1) and connexin (Cx) 43-mediated gap junction [9]. In
hypertrophic adult rat VCMs, down-regulation of miR-1/miR-
133 levels promotes automaticity via up-regulation of HCN2/
HCN4, but this defect can be reversed by forced expression of
miR-1/miR-133 [10,11]. Various recent profiling efforts have
further revealed profound alterations of miR expression in the
pathogenesis of human heart failure [12–14]. Despite the
knowledge gained from these studies, however, the functional
roles of miRs in human cardiogenesis remains elusive due to the
paucity of cause-and-effect data in human heart cells. Given that
significant species differences are known to exist (e.g., miRs that
regulate pluripotency genes were discovered in mouse but many
have no known human homologs [15]), further studies of miRs in
human heart cells are therefore warranted. Using self-renewable,
pluripotent human (h) embryonic stem cells (ESCs) [16], along
with primary human fetal (hF) and adult (hA) heart cells, we
uncovered miRs that figure prominently in cardiac specification
and development. Specifically, our experiments demonstrate that
miR-499 promotes ventricular specification while miR-1 serves to
facilitate their electrophysiological maturation.
Materials and Methods
Cell Culture and Cardiac differentiation
The HES2 (ESI, Singapore) hESC line was maintained on
irradiated mouse embryonic fibroblasts (MEF) at 37uC with 5%
CO2. The culture medium consisted of DMEM/F12 (Invitrogen)
supplemented (all from Invitrogen) with 15% knockout serum, 1%
non-essential amino acids, 1 mmol/L L-glutamine, 0.1 mmol/L
b-mercaptoethanol, and basic fibroblast growth factor of 20 ng/
ml. Specification of human tripotent KDR
low/c-kit
neg cardiovas-
cular progenitors into CMs using the activin, BMP-4 and VEGF
induction was as reported [17]. In brief, hESCs were suspension-
cultured to form cardiogenic embryoid bodies (EBs) or ‘‘cardio-
spheres’’ under serum- and feeder-free conditions. At day 1, the
aggregates were incubated in media containing Activin A, and
BMP-4, at 37uC under low (5%) oxygen for 4 days. At day 4,
Activin A and BMP-4 were removed, followed by replenishing
with media containing hDKK1 and VEGF. At day 8, cardio-
spheres were provided with fresh media, and fed again at day 12,
supplied with bFGF and incubated at 37uC under normal ambient
oxygen conditions. Fresh media was supplied every 3–4 days.
Cardiac derivatives typically appeared after 12,14 days. The
yield of hESC-derived CMs with this method of directed cardiac
differentiation is typically ,50% as gauged by troponin T
expression [17] (vs. ,,1% by the conventional method of EB
formation [18] as specified in some of the experiments).
Isolation of hESC-derived CMs and Lentivirus (LV)-
mediated gene transfer
Human ESC-derived CMs are known to contain a heteroge-
nous population of ventricular, atrial and pacemaker derivatives
[18–20]. For profiling experiments, ventricular (V) hESC-CMs
were purified to avoid ambiguities due to the presence of
contaminating non-ventricular CMs and non-cardiac cells. To
accomplish this, post-differentiation 20-day old cardiospheres were
transduced by recombinant LV-MLC2v-mCherry particles at a
titer of .10
6 and an MOI of 3. The efficacy of using the myosin
light chain-2v promoter (MLC2v) to drive the expression of a
reporter protein for identifying ventricular CMs, as we recently
reported [21], was first confirmed by two independent methods: 1)
Figure S1 shows that only human fetal left ventricular CMs, but
not HEK293, cells expressed mCherry after LV-MLC2v-mCherry
transduction, indicating the cardiac specificity of our construct. 2)
Upon transduction of hESC-CMs by LV-MLC2v-mCherry,
fluorescent cells typically appeared 72 hours later and could be
FACS-sorted (BD FACSAria
TM II). Electrophysiologically,
mCherry
+ hESC-derived CMs displayed ventricular action
potentials (AP), exclusively (n=15). FACS-sorted ventricular
hESC-CMs were immediately used for miR/RNA extraction.
Single hESC-CMs were isolated for electrophysiological exper-
iments as previously described [20,22,23] Beating outgrowths were
microsurgically dissected from HES2-derived cardiospheres
(20,24 days) by a glass knife, followed by incubation in
collagenase II solution (1 mg/ml) at 37uC for 30 min. The
isolated cells were incubated with KB solution containing (mM):
85 KCl, 30 K2HPO4, 5 MgSO4, 1 EGTA, 2 Na2-ATP, 5 pyruvic
acid, 5 creatine, 20 taurine, 20 D-glucose, at room temperature for
30 min. After the cells were plated on laminin-coated glass
coverslips for 1 hr at 37uC, the culture media was added carefully
and refreshed the next day. For miR overexpression, LV-CMV-
miR-X-EF1a-GFP (System Biosciences, Mountain View, CA), or
LV-miR-X
TM for short, was incubated overnight, followed by
replacing with fresh media. Positively transduced cells were
identified by GFP and used for experiments 4 to 7 days after
transduction. For controls, the identical backbone described above
without any miR coding sequence (i.e. LV-CMV-BLANK-EF1a-
GFP or LV-BLANK) or an antagomir (LV-CMV-anti-X-EF1a-
GFP or LV-anti-X) as designed and recommended by System
Bioscience was used as indicated. Specific miR overexpression of
the experimental groups was confirmed by qPCR.
Isolation of human fetal and adult ventricular CMs
Human fetal (hF) and adult (hA) left ventricular (V) CMs were
isolated and experimented according to protocols approved by the
UC Davis IUPAC and IRB (Protocol #200614787-1 and #
200614594-1). Briefly, fetal human hearts (16–18 weeks, Ad-
vanced Bioscience Resources, INC. Alameda, CA) and adult
human hearts (18+ years, National Disease Research Interchange,
Philadelphia, PA) were perfused with enzymatic solutions using a
customized Langendorff apparatus as we previously described
[24].
MiR and Transcriptomic Profiling
Cell samples were suspended and lysed in Trizol (Invitrogen).
After adding 1:4 volume chloroform, aqueous and organic phases
were separated using heavy PLG tubes (Eppendorf). MiRs was
extracted from the aqueous phase using the miRNeasy kit
(Qiagen, Valencia, CA), and stored at 280uC before use.
Microfluidic uParaflow chips (Atactic Technologies, Houston
TX) containing probes for Sanger microRNA Database v11.0
were used to profile miR expression; Sentrix WG-6 beadchips
(Illumina, San Diego, CA) were used to profile mRNA expression.
Microarray data were analyzed using the WebArrayDB for miRs
(Sidney Kimmel Cancer Center, San Diego, CA) and BeadStudio
for transcriptomic (Illumina) software packages [25]. Expression
was normalized using background subtraction and cubic spline
(BeadStudio) or composite LOESS normalization (WebArrayDB).
Differential expressions in microarrays were assessed using the
Analysis of Variance test (ANOVA) and results with p-value ,0.05
were considered to be significant.
Electrophysiological characterization
Electrophysiological experiments were performed using the
whole-cell patch-clamp technique with an Axopatch 200B
amplifier and the pClamp9.2 software (Axon Instruments Inc.,
Functional Roles of MicroRNA-1 & -499 in hESC-CMs
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27417Foster City, CA) [26,27]. Patch pipettes were prepared from
1.5 mm thin-walled borosilicate glass tubes using a Sutter
micropipette puller P-97 and had typical resistances of 4–6 M
when filled with an internal solution containing (mM): 110 K
+
aspartate, 20 KCl, 1 MgCl2, 0.1 Na-GTP, 5 Mg-ATP, 5 Na2-
phospocreatine, 1 EGTA, 10 HEPES, pH adjusted to 7.3 with
KOH. The external Tyrode’s bath solution consisted of (mM): 140
NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, pH
adjusted to 7.4 with NaOH. Voltage- and current-clamp
recordings were performed at 37uC within 4 to 7 days after LV-
miR-X
TM transduction. For action potential (AP) recording, the
hESC-CMs were stimulated with 0.1–0.5 nA for 1–5 ms. Human
ESC-CMs were categorized into pacemaker, atrial or ventricular
phenotypes according to standard AP parameters (summarized as
Table S1) as we and others previously described [19,20]. Numeric
details of this current work are given in Table S2. Voltage-clamp
recordings of ionic currents were performed using standard
electrophysiological and pharmacological protocols for isolating
the ionic component of interest (see supplemental information for
details). Current- and voltage-clamp recordings were performed
on the same cells so that the AP phenotypes and electrophysio-
logical properties could be directly examined for correlation.
Measurements of cytosolic Ca
2+
Ca
2+ transients of hESC-derived CMs were made as we
previously reported [24,28,29]. In brief, hESC-CMs were
incubated with 5 mM Fura-2/AM and 0.2% pluronic F-127 for
30 min at 37uC. Fluorescent signals obtained upon excitation at
340 nm (F340) and 380 nm (F380) were recorded from cells
perfusing with Tyrode’s solution containing (mM): 140 NaCl,
5 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, and 10 HEPES. The F340/
F380 ratio was used to represent cytosolic [Ca
2+]i. To elicit
cytoplasmic Ca
2+ transients, hESC-CMs were electrically pulsed
(0.1 to 0.5 Hz). Ca
2+ transients were recorded and analyzed after a
series of depolarization that enabled each transient to fully decay
so as to establish a steady-state. Data were analyzed using the
Ionwizard software (Version 5, IonOptix) to generate the Ca
2+
transient parameters reported. Amplitude of Ca
2+ transient is
defined as the ratio of F340/F380. Maximum upstroke velocity and
maximum decay velocity were (F340/F380)/duration of the steepest
slopes of the upward and decay phases, respectively.
Real-time PCR
Total RNA was extracted with RNeasy Mini kit (Qiagen) and
measured (A260/A280) by spectrophotometry. Reverse transcrip-
tion was done with the QuantiTect Reverse Transcription Kit
(Qiagen). Quantitative PCR was carried out using Platinum SYBR
green qPCR SuperMix-UDG (Invitrogen) and MyiQ Optical
Module (Bio-Rad) according to the manufacturer’s instructions.
Primers were designed using Oligo Perfect Software (Invitrogen,
Table S3). To validate miR overexpression, reverse transcription
was done with the QuantiMiR Reverse Transcription Kit (System
Biosciences). Quantitative PCR was carried out using Platinum
SYBR green qPCR SuperMix-UDG (Invitrogen) and MyiQ
Optical Module (Bio-Rad). The forward primer was using the
same sequence of mature miRs, and the universal reversed primer
was provided in the QuantiMiR Kit. In triplicate, select miRs were
compared against undifferentiated hESCs as well as the 4
endogenous controls, nucleolar RNAs RNU38B and RNU48 (as
recommended by the array manufacturer) and the stably
expressed miRs, miR-188 and miR-296-5p (as identified in our
own experiments) (Figure 1D). Of note, miR-188 was shown to
display the most stable expression profile across all cell types
examined. For each cell type, the 2DCT was calculated for each
miR (2DCT=21*[median sample CT2median control CT])
paired with each of the 4 endogenous controls. In other words,
four 2DCT values were individually generated for each miR of
the four types investigated. Each 2DCT value was then scaled by
the background 2DCT value, which had been termed 2DCT0
(where DCT0=DCT background2DCT control; assuming a CT of 35
or higher is equal to zero expression). Any miR with a CT$35 was
rounded to 35. ANOVA analysis was performed and significant
differences had p values less than or equal to 2.59E-5.
MTT assay for cell viability
Cell viability of control or experimental groups was determined
using a colorimetric 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenylte-
trazolium bromide (MTT) kit (Roche Diagnostics). In brief, MTT
(10 ml) labeling reagent (5 mg/ml in PBS) was added to cells,
followed by incubation at 37uC for 4 hours. Solubilization solution
(100 ml) was added to dissolve the formazan crystals formed.
Absorbance at 540 nm was measured by a spectrophotometer.
MiR Target Analysis
Predicted mRNA targets of miRs were identified using three
algorithms, namely miRanda [30], TargetScan 5.0 [31], and
PicTar [32]. Because miRs are negative transcriptional regulators,
the list of candidate mRNA targets were further filtered for
pathway analysis by a reciprocal relationship between miRs and
mRNA transcripts as further elaborated later. To improve the rate
of false positive detection at low expression levels, candidates were
only analyzed if the transcripts had at least a two-fold difference in
expression level between undifferentiated hESC and each of hE-,
hF- and hA-VCMs at normalized intensity values of 1000 or
greater or at least a three-fold difference in expression level when
intensity values are less than 1000.
Statistics
Data are expressed as mean6S.E.M. Statistical significance of
differences in means was estimated by unpaired Student’s t test, or
Chi-square (x
2) test, or ANOVA analysis. P,0.05 was considered
statistically significant.
The authors had full access to the data and take responsibility
for its integrity. All authors have read and agreed to the
manuscript as written.
Results
Differentially expressed miRs in hESC-derived, fetal and
adult ventricular CMs, but not undifferentiated hESCs
We hypothesized that cardiomyogenic associated miRs would
be differentially expressed in differentiating, developing, and
terminally mature CMs. As a first step, we chronologically
mapped the miR profiles of undifferentiated hESCs, hESC-
derived (hE), fetal (hF) and adult (hA) ventricular (V) CMs.
Figure 1A shows that 63 miRs were differentially expressed
between hESCs and hE-VCMs (p,0.05). Of these, 29 showed
signal intensities at least four-fold higher in hESCs than any of hE-,
hF- and hA-VCMs (Figure 1A, top right panel). Particularly, the
miR-302 cluster (miR-302a, -302a*, -302b, -302b*, -302c, -302c*,
-302d, and -302d*) located within intron 8 of LARP7 and the 371/
372/373 cluster (miR-371-3p, -371-5p, -372, and -373) located
within an intergenic region of chromosome 19 have been previously
shown to associate with pluripotency [33–35]. The remaining 34 of
63 differentially expressed miRs were all higher in hE-VCMs.
Importantly, only twenty-three miRs continued to be highly
expressed in hF- and hA-VCMs (Figure 1A, bottom right panel),
suggesting a potential role in specification or maturation. Their
Functional Roles of MicroRNA-1 & -499 in hESC-CMs
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27417Figure 1. Characterization of miRNAs Present in hESC and Ventricular CMs. (A) A heatmap showing the results of ANOVA differential
expression analysis; 63 miRs were differentially expressed between undifferentiated human ESC and hESC-derived VCMs (p,0.05). Red to green
indicates high to low expression. Right panels: Average signal intensities of the 29 miRs differentially expressed in hESC (top), and the 23 miRs that
displayed a ‘‘plateau’’ pattern across E-, F- and A-VCMs (bottom). (B) ‘‘Plateau’’ miRs validated with quantitative RT-PCR. (C) After normalized with the
values of hESCs, miR-1, -133, and -499 displayed the highest differential expression between VCMs and hESCs. (D) MiR-188 and -296 were identified as
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compared with hESCs, and remained at the same relative high
levels throughout development into hF- and hA-VCMs. Of note,
miR-30a, -30b, -30d, -30e are derived from different regions of the
genome but have the same seed sequence (i.e. nucleotides 2–7 on
the mature miRs) which is crucial for target selection during RNA
interference-mediated inhibition or degradation [36,37]. This holds
true for the miR-27, -133, and -let-7 families, with each family
sharing their own identical seed sequences. The profiles of miR-1,
let-7a, let-7b, miR-26b, miR-30b, miR-125a, miR-126, miR-133a,
miR-143, and miR-499 in hE/F/A-VCM were confirmed by
qPCR (Figure 1B). MiR-let-7a, -let-7b, -26b, -125a and -143 were
also significantly expressed in human fibroblasts (data not shown),
indicating their non-cardiac specificity.
The ventricular-restricted expression pattern of miR-1, -30b, -
126, -133, and -499 starkly contrasted the reverse pattern of
pluripotency-associated miRs that were differentially expressed in
hESCs, and the stable expression levels of miR-188 and -296,
which remained relatively unchanged across the different
developmental stages examined as reflected by the small variances
(Figure 1A, D). Indeed, the stability of miR-188 and -296 was
comparable to the endogenous controls RNU38B and RNU48.
Quantitative PCR confirmed these patterns and further showed
that among all the plateau miRs identified (cardiac-specific or not),
miR-1, -133, and -499 were most differentially expressed in hE-,
hF- and hA-VCMs relative to hESCs after scaling the DCT values
of each VCM type by the corresponding hESC value (with ratios
of 15.0, 15.8, and 12.9, respectively versus 5.1 to 9.4 of the other
seven miRs; Figure 1C). As anticipated from the data presented
above, principal component analysis revealed cell-specific cluster-
ing of hESC, hE-, hF- and hA-VCMs (Figure 1E). Between-group
analysis (BGA) provides a visual means to observe the variance of
the data set. Each sample is grouped along the axes according to
similar miR expression. Figure S2 summarizes our criteria for
selecting miR-1, -133 and -499 for further experiments.
PRE-cardiac differentiation alteration of miRs
To test the possibility that miRs expressed in hE-CMs but not
hESC and continued to increase in their expression levels in hF-
and hA-VCMs are crucial for ventricular specification and
maturation, we systematically performed lentivirus (LV)-mediated
transduction for over-expressing these miRs individually in hESCs
and hE-CMs to shed insights into their roles before and after
cardiac induction, respectively. Compared to controls (WT, LV-
BLANK), stable transduction of hESCs by LV-miR-499 or -1 did
not affect the transcript expression of pluripotency genes (Oct4,
Nanog) or upregulate cardiac genes (a myosin heavy chain or
MHC, b myosin heavy chain, troponin T) that are not expressed
in the undifferentiated state (p.0.05). These results suggested that
overexpression of miR-499 or -1 alone was insufficient to drive
cardiac differentiation or compromise pluripotency. Upon cardiac
differentiation of stably LV-miR-1-transduced hESCs by EB
formation, however, all of a-MHC and b-MHC were significantly
upregulated (2- and 3-fold increases, respectively) compared to
EBs derived from control WT hESCs (p,0.05). This observation
was consistent with the upregulation of NKX2.5 seen in EBs
differentiated from LV-miR-1-transduced, but not LV-miR-133-
transduced or WT, H7 hESCs that Srivastava and colleagues
reported [8]. Similar to the pro-cardiogenic role of miR-1, b-
MHC also became significantly upregulated (2.5-fold; p,0.05) in
EBs from stably LV-miR-499-transduced hESCs, although a-
MHC was unaffected (p.0.05). By contrast, the expression levels
of a-MHC and b-MHC were not different between WT and LV-
anti-miR-499 hESC-derived EBs. Taken collectively, these results
suggest that miR-1 and -499 play similar but distinct roles. The
experiments that follow were designed to further dissect their
similarities and differences.
POST-cardiac differentiation alteration of miRs
To study the roles of miR-1 and -499 at a later stage of cardiac
induction and chamber specification, we next transduced 20-day
old cardiospheres derived by directed differentiation of WT hESCs
[17]. When normalized to the control group, transduction of hE-
CMs by LV-miR-1, -133 and -499 led to significant 27.461.4-,
2.560.3- and 20.762.2-fold increase in the corresponding miRs,
respectively (p,0.05). To assess any cytotoxic effect that miR-1, -
133 or -499 expression might have on hE-CMs, a colorimetric
MTT assay for cellular metabolisms was performed. No significant
differences were observed among the control and experimental
LV-miR-1-, 133- and -499-transduced groups (p.0.05; Figure
S3).
Under control conditions, signature ventricular, atrial or
pacemaker APs were observed by patch-clamp recordings of
dissociated single hE-CMs (Figure 2A–B; n=93). The percentage
of ventricular AP observed was 48.5% (45 of 93 cells). Consistent
with an immature embryonic-like phenotype, APs of hE-VCMs
had a depolarized resting membrane potential (RMP,
251.461.1 mV, n=45) or maximum diastolic potential (MDP,
269.761.0 mV), with slowed upstroke and decay velocities
(3.060.2 mV/ms and 20.2560.02 mV/ms, respectively, n=45)
(Figure 3). Interestingly, LV-miR-499 transduction significantly
increased the yield of the ventricular lineage to 72.0% (18 of 25
cells, p,0.05; Figure 2B) without affecting the various AP
parameters measured (Figure 3; p.0.05). Consistent with our
pre-differentiation transduction experiments already presented,
LV-miR-499 transduction of hE-CMs likewise significantly
upregulated a-MHC, b-MHC, as well as myosin light chain
(MLC) 2v, a-actin and troponin T (p,0.05; Figure 2C). In
particular, the increase of b-MHC was the highest (,5-fold),
consistent with a pro-ventricular effect. By contrast, none of miR-
1, -133 and –anti-499 exerted any effect on contractile proteins
(p.0.05). LV-miR-1 (55.0% or n=17 of 31, p.0.05), 2133
(52.9% or n=9 of 17, p.0.05) and –anti-499 (44.4% or n=4 of 9,
p.0.05) transduction also did not affect the ventricular yield.
Although the ventricular yield was unchanged by miR-1,
however, LV-miR-1 transduction of hE-CMs appeared to
uniquely facilitate electrophysiological maturation: APD50 and
APD90 decreased from 197.0620.7 ms and 240.8623.1 ms in
control hE-VCMs to 139.7614.2 ms and 174.7616.6 ms (n=17,
p,0.05; Figure 3B–C) after miR-1 transduction, respectively. The
stably expressed across developmental stages, at levels comparable to standard endogenous controls RNU38B and RNU48. Conversely, the
expression of miR-1, -499, and -133 varies greatly across developmental stages. The box plot for each sample summarizes the median, first and third
quartiles and range of raw CT values for each miRNA or endogenous control in all cell types assayed. (E) Between-group analysis (BGA) was carried
out using principle component analysis (PCA) to provide a visual means to observe the variance of data in specified groups (G) along G-1 number of
axes. Data points corresponding to individual miRs are distributed along the axes according to discriminating eigenvectors. Data points and groups
that are strongly associated will be clustered within the graph due to their similar projection (both direction and distance) from the origin. Detailso n
the calculations used in BGA can be found in Culhane et al. (2002) [38].
doi:10.1371/journal.pone.0027417.g001
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Figure 3D) although the upstroke velocity was not altered
(p.0.05; Figure 3E). Furthermore, RMP and MDP became
significantly hyperpolarized to 256.661.9 mV (p=0.026) and
273.261.3 mV (p=0.024), respectively (Figure 3F–G). LV-anti-
miR-1 did not affect these AP parameters (Figure S5). Neither LV-
miR-1 nor -499 had effects on hE-derived atrial CMs when their
percent distribution and AP parameters were assessed (Figure 2,
Figure S4 and Table S2), suggesting that the effects observed were
ventricular-specific. Indeed, miR-21 and -29, robustly expressed in
adult CMs (.5-fold higher than hE- and hF-CMs) according to
our profiling data confirmed by qPCR, when overexpressed in
hESC-CMs by LV transduction, did not alter any of the action
potential properties assessed (data not shown). Collectively, our
results indicated that miR-1 and -499 had specific and differential
effects on ventricular specification and maturation.
Ionic Basis of the effects of miR-1 on hESC-VCMs
Different ionic channels are known to underlie the different
phases of ventricular APs. To investigate these potential
mechanisms, we sought to identify changes in ionic components
after transduction by probing for the transcriptional changes of
several ion channels (Kir2.1, HCN4, Kv1.4, Kv4.3, HERG,
SCN5A, L-type Cav or DHPR) known to be important in
Figure 2. Electrophysiological and Molecular Properties of Control and miR-1, -133, and -499 Transduced hE-VCMs. A) Representative
tracings of ventricular, atrial and pacemaker action potentials (APs) of control hESC-CMs. B) The percentage distribution of ventricular, atrial and
pacemaker phenotypes before and after LV-miR-1 or -miR-499 transduction. C) Transcriptional expression of cardiac sarcomeric genes in LV-miR-1-,
133- and 499-transduced hESC-CMs. *, p,0.05.
doi:10.1371/journal.pone.0027417.g002
Functional Roles of MicroRNA-1 & -499 in hESC-CMs
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27417ventricular biology. Figure 4A shows that LV-miR-1 transduction
led to significant (p,0.05) up-regulation of the Kir2.1, Kv1.4,
HERG, and DHPR transcripts and down-regulation of HCN4.
The Kv4.3 and SCN5A transcripts were unaffected (p.0.05).
Since changes at the transcript level do not always translate into
functional changes, we performed voltage-clamp recordings.
Figure 4B shows that LV-miR-1-transduced hE-VCMs expressed
nifedipine-sensitive (5 mM) L-type Ca
2+ channels (ICa, L), a
depolarizing component that underlies the Phase 2 plateau phase,
with current densities, steady-state activation and inactivation
properties not different from control hE-VCMs (p.0.05). Of note,
ICa, L expressed in hE-VCMs were comparable to those found in
hA-VCMs. ZD7288-sensitive (30 mM) hyperpolarization-activated
pacemaker current (If) that is crucial for Phase 4 depolarization
[26,39–42] not seen in normal healthy hA-VCMs but present in
hE-VCMs, was modestly yet significantly reduced (p,0.05, n=7;
Figure 4E–F) consistent with HCN4 transcript down-regulation.
Steady-state activation curve was unaltered (p.0/05; Figure 4G).
No IK1 could be recorded (n=6). Nav currents were also not
different (data not shown). Hyperpolarizing K
+ currents that are
crucial for repolarization such as the transient outward current
(Ito), the slow (IKs) and rapid (IKr) components of the delayed
rectifier, pharmacologically separated by their specific blockers 4-
aminopyridine (4AP; 100 mM), Chromanol 293B (30 mM) and
E4031 (10 mM), respectively, were weakly expressed or absent in
control hE-VCMs but became significantly augmented after LV-
miR-1 transduction (Figure 5, p,0.05).
MiR-1 improves Ca
2+-handling properties
Previous reports have indicated that hE-CMs display immature
Ca
2+-handling properties with smaller Ca
2+ transient amplitudes
and slower kinetics (rise and decay) than those of the adult
Figure 3. AP Parameters of Control and miR-1 and -499 Transduced hE-VCMs. A) Representative AP tracings of Control, LV-miR-1- and -
miR-499-transduced hESC-derived ventricular derivatives as labeled. B-G) Bar graphs summarizing the AP parameters APD50, APD90, repolarization
velocity, upstroke velocity, resting membrane potential (RMP), and maximum diastolic potential (MDP) of the groups in A).
doi:10.1371/journal.pone.0027417.g003
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27417Figure 4. Effects of miR-1 transduction on electrophysiological and molecular properties of hESC-derived CMs. A) Transcriptional
expression of sarcolemmal ion channels (Kir2.1, HCN4, Kv1.4, Kv4.3, HERG, SCN5A, DHPR) in hESC-CMs after LV-miR-1 transduction. B) Representative
tracings of ICa,L of control and LV-miR-1-transduced hE-VCMs as labeled. Currents were elicited by the electrophysiological protocol given in the inset.
Currents shown were nifedipine-sensitive. C–D) The corresponding current-voltage (I–V) relationship, steady-state activation (circle) and inactivation
curves (square) of ICa,L. E) Representative tracings of If recorded from control and LV-miR-1-transduced hE-VCMs. Currents were elicited by the
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LV-miR-1 (n=17) but not 2133 (n=18), 2499 (n=26), anti-1
(n=12), or -anti-499 (n=15) transduction significantly augmented
the transient amplitude and hastened the upstroke velocity
(Figure 6A–D and S6), rendering these parameters more adult-
like. However, the decay velocity was unaltered (p.0.05).
Consistently, after LV-miR-1 transduction, the transcripts of
junctin (Jnct), triadin (Trdn) and ryanodine (RyR2) that play a role
in Ca
2+ release were significantly up-regulated (p,0.05) whereas
that of SERCA2a for Ca
2+ re-uptake was not affected (p.0.05;
Figure 6E). Calreticulin (CalR), calsequestrin 2 (CSQ2) and
phospholamban (Phlmb) were also unaltered (p.0.05).
Target and pathway analyses of MiR-1 and -499
Next we performed target and pathway analyses of miR-1 and -
499. Using established algorithms, we generated a list of 1448 and
1226 predicted mRNA targets for miR-1 and -499, respectively.
These predicted target genes were analyzed for relevant Gene
Ontology (GO) classifications and Map Annotation and Pathway
Profile (MAPP) pathways involved in CM functions such as
hypertrophy, ion channel regulation, contraction, etc. The
numbers of genes in each of these select pathways and the
numbers of predicted miR-1 and -499 targets in these pathways
are given in Table S4. Indeed, miR-499 and miR-1 shared a
number of overlapping targets including those that are known to
play important roles in early cardiogenesis. Among these, GATA4
is a predicted target of miR-499 but not miR-1. Consistent with
this prediction, transduction of hE-CMs by LV-miR-499, but not
LV-anti-miR-499, led to a 3-fold downregulation of GATA4
(p,0.05). Interestingly, LV-miR-1-transduction of hE-CMs sig-
nificantly upregulated GATA4 (by 15-fold; p,0.05). In stark
contrast, MESP1 was affected by none of LV-miR-1, miR-499 or
–anti-miR-499 (p.0.05). Interestingly, LV-miR-499, but not -
anti-499 or –miR1, upregulated MEF2C (by ,2.5-fold, p,0.05).
To obtain a global view for additional insights, we next
performed microarray transcriptomic analysis. Since an abun-
dantly expressed miR is anticipated to down-regulate its target
transcripts, we aimed to experimentally fine-tune our list of predicted
targets by profiling their expression. Figure 7A shows the
transcriptional profile heatmaps of miR-1 and -499 predicted
targets identified in the selected GO/pathways as indicated.
Similar to the reciprocal relationship described for normal and
failing adult human CMs [14], we identified multiple functional
groups of transcripts that were expressed at low levels (i.e. green) in
the miR-1 and miR-499 abundant hE-, hF- and hA-VCMs. The
numbers of these genes and their percentages relative to the total
genes in each selected pathway or GO classification are
summarized in the pie charts given in Figure 7B–C and in Table
S4. These putative miR-1 and -499 targets agreed with our
transcriptomic data and met one of two criteria: 1) The gene was
expressed below a normalized log2 value of 1.0 (,500 signal
intensity units) in all CM types assayed or 2) The gene was
expressed below a normalized log2 value of 2.0 (,1000 signal
intensity units) AND was expressed at least 2-fold lower in hE-, hF-
and hA-VCMs compared with undifferentiated hESCs. According
to these analyses, miR-499 is most closely associated with the
regulation of embryonic stemness, cell proliferation, cell size and
apoptosis; whereas, miR-1 is implicated in control of embryonic
stemness, cell cycle, hypertrophy and cell size.
Discussion
Although miRs have been implicated in heart development,
their roles in human heart cells require further studies. In
particular, the functional effects of miRs on the electrophysiolog-
ical and Ca
2+-handling properties of human CMs have not been
investigated. In the present study, we have identified miR-499 and
-1 as determinants of ventricular specification and maturation of
human CMs, respectively. Consistent with the anticipated multi-
faceted roles of miRs, miR-1 and -499 exert multiple but specific
effects on a range of ion channel, Ca
2+-handling and contractile
proteins known to be important in ventricular biology. Further
analyses suggest that these events were orchestrated consequences
of numerous cellular changes directly regulated by miR-499 and -
1.
Although miR-499 is up-regulated in human mesenchymal stem
cells upon in vitro propagation [23], its role and involvement in
human cardiogenesis or cardiac differentiation of hESCs has not
been demonstrated. Interestingly, miR-499 is located within intron
20 of MYH7B on chromosome 20 and is highly conserved in
vertebrates. Our present study reports that miR-499 promotes
ventricular specification and significantly augments b-MHC
expression in hE-CMs, although it has no effect on the
electrophysiological and Ca
2+-handling properties. By contrast,
miR-1 has no effect on the percent yield of VCMs from hESC
differentiation, but it uniquely facilitates electrophysiological and
Ca
2+-handling maturation by altering the expression levels of
several immature related components (Ito,I Kr,I Kr and If) to levels
closer to those of adults. The effect on Ca
2+-handling was
consistent with a recent report of miR-1 enhancing excitation-
contraction coupling by increasing phosphorylation of L- type and
RyR2 channels [43]. Of note, however, a hyperpolarization
overshoot followed by a Phase 4-like depolarization, pro-
arrhythmic traits not observed in mature adult VCMs, were
present in both control and LV-miR-1-transduced cells, indicating
that the pro-maturation effect of miR-1 was at best partial.
In adult rat ventricular myocytes, miR-1 overexpression has
been shown to markedly increase ICa,L [43] and suppress the a and
b subunits of IKs (i.e. KCNQ1 and KCNE1) [44]. However, our
experiments showed that hE-VCMs already expressed ICa,L at a
level comparable to that in adult and ICa,L remained unaltered
after LV-miR-1 transduction. By contrast, IKs was not expressed in
hE-VCMs but was up-regulated by LV-miR-1. These results
suggest that the effects of miR-1 on VCMs are context-dependent.
Furthermore, miR-1 overexpression in hESC-VCMs led to the
upregulation of some ionic currents. It is possible that miR-1
targets a transcriptional or translational repressor or negative
functional inhibitor of these ion channels, Adding another level of
complexity is our previously reported observation that the
transcript levels and functionality of ion channels do not
necessarily correlated [27] because ion channel functions (gating
and permeation) often depend on the presence of accessory units
(such as beta subunit) and other factors (e.g., post-translational
modification such as glycosylation). Further investigations are
required to better understand the underlying relationships.
The two variants of miR-1 identified to date, miR-1-1 and 1-2,
share the identical mature sequence and are located within intron
2 of an uncharacterized gene C20ORF166 and intron 12 of the E3
ubiquitin-protein ligase MIB1 (Mindbomb Homolog 1) on
chromosomes 20 and 18, respectively. Interestingly, miR-133a
electrophysiological protocol given in the inset. Currents shown were ZD7288-sensitive. F–G) The corresponding current-voltage (I–V) relationship
and steady-state activation curve of If.*p ,0.05.
doi:10.1371/journal.pone.0027417.g004
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PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27417Figure 5. Currents and Current-Voltage Relationships in Control and miR-1 Transduced hE-VCMs. A, C and E) Representative tracings of
Ito,I Kr and IKs recorded from WT, LV-miR-1-transduced E-VCMs as labeled. Currents were elicited by the electrophysiological protocol given in the
inset. Currents shown were 4-Aminopyridine-, Chromanol 293B- and E4031–sensitive, respectively. B, D and F) The corresponding current-voltage (I–
V) relationships. *, p,0.05.
doi:10.1371/journal.pone.0027417.g005
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and -1-2 are found [45]. As such, miR-1 and -133 are considered
single ‘‘miR genes’’ which are transcribed and processed to
generate the corresponding mature miRs. Indeed, miR-133 has
been implicated in early cardiac differentiation of murine and
human ESCs by repressing the non-mesoderm lineages, rather
Figure 6. Calcium Handling in Control and miR-1, -133, and -499 Transduced hE-VCMs. A) Representative tracings of Ca
2+ transients
recorded from control, LV-miR-1-, 133- and 499-transduced hESC-CMs. B–D) Comparison of amplitude (B), maximum upstroke velocity (Vmax-upstroke,
C), and maximum decay velocity (Vmax-decay,D )o fC a
2+ transients in control and LV-miR-transduced hESC-CMs as indicated. E) Transcriptional
expression of Ca
2+-handling proteins. *, p,0.05.
doi:10.1371/journal.pone.0027417.g006
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miR-133 exerts no effects on Ca
2+-handling and contractile
proteins when cardiovascular progenitors of later stages were
transduced. Taken collectively, the results suggest that key
cardiogenic miRs and gene products cluster together at specific
chromosomal locations for effective regulations.
Our finding that pre- and post-differentiation transduction with LV-
miR-499 similarly led to b-MHC upregulation hints at the possibility
that miR-499 exerts its pro-cardiogenic action after cardiac differentiation is
initiated. This is consistent with the finding that stably LV-anti-miR-499-
transduced hESCs were able to efficiently differentiate into hE-CMs
with levels of GATA4, a-MHC and b-MHC not different from those
of WT EBs. Indeed, MEF2C that is required for contractile protein
activation also remains unchanged even after successful stable
suppression of miR-499 by LV-anti-miR-499. During the course of
our manuscript preparation, van Rooij et al reported that a family of
miRs encoded by myosin genes, including miR-499, governs myosin
expression and muscle performance [46]. Using an elegant transgenic
mouse model, they demonstrated that miR-208a is required for
expression of b-MHC/miR-499 but its cardiac functions can be
replaced by miR-499, suggesting the latter as a downstream mediator.
Consistently, Sluijter et al. independently identified the upregulation of
miR-1 and -499 in beating cardiomyocytes differentiated from human
fetal cardiac progenitors [47]. Transient transfection to overexpress
miR-1 or -499 in these human progenitors reduces their proliferation
by repressing histone deacetylase 4 or Sox6 although no functional
properties were reported. Most recently, Hosoda et al shows that miR-
499 targets Sox6 and Rod1, traverses gap junction channels and
translocates to structurally coupled human cardiac stem cells,
enhancing their cardiomyogenesis in vitro and after infarction in vivo
[48]. In another separate study [49], we reported that miR-499 are
strongly associated with cardiac differentiation and share many
predicted targets with miR-208 that has been previously shown to
associate with cardiac development. Furthermore, overexpression of
miR-499 or -1 results in upregulation of important cardiac myosin
heavy-chain genes in embryoid bodies; miR-499 overexpression also
causes upregulation of the cardiac transcription factor MEF2C. Taken
collectively, these independent studies and ours strongly suggest an
important biological role of miR-499 in cardiac differentiation. Our
present study focuses on and further demonstrates the functional
implications of miR-499 and -1 in the context of cellular electrophys-
iological and Ca
2+-handling properties. We also showed that GATA4
is a probable target of miR-499 but not miR-1. However, our data did
not allow us to exclude the possibility that GATA4 down-regulation
was merely an indirect or secondary effect. Identification of additional
common and distinct targets of miR-499 and -1 requires extensive
validation but could help dissect their overlapping and differential roles
in cardiac differentiation.
Cardiac differentiation involves at least two processes: 1)
downregulation of stemness genes that leads to the loss of
pluripotency, and 2) up-regulation of cardiac gene products (such
as heart-specific transcription factors, etc) that subsequently drives
cardiac differentiation, followed by chamber-specific specification
of cardiac progenitors. While the loss of pluripotency is universally
required for differentiation into any lineages, cardiac differentia-
tion and specification likely involves multiple heart-restricted
factors and miRs. We are proposing that upon the initiation of
cardiac differentiation, miR-499 serves to promote ventricular
specification. This notion is supported by the finding that miR-499
over-expression increases the ventricular yield, although miR-499
per se may not be absolutely necessary for initiating cardiac
differentiation. Indeed, the lack of effect of anti-miR-499 is
consistent with its lack of expression in undifferentiated hESCs but
a cardiac fate has been acquired.
One possible limitation of the present work is that these our
experiments were primarily performed in vitro with hESC as our
model. In developing organisms, cell fates are influenced by signals
from surrounding tissues and in heart, by well-characterized
differentiation factors such as Nkx2.5, Hand2, Mef2 and Tbx5
[50–53]. In this regard, Langendorff isolated hE-, hF- and hA-
VCMs,andinvitrohESC-anddirected cardiacdifferentiation-based
models, may not completely recapitulate the in vivo setting. Indeed,
although stably LV-anti-miR-499-transduced hESCs could differ-
entiate into hE-CMs, our preliminary experiments of injecting
zebrafish embryos with miR-499 or -1 anti-sense probes, but not
blank or scrambled sequences, led to significant anatomical and
functional heart defects, suggestive of an in vivo role.
An inhibitory effect of miR-499 on atrial specification would
also lead to an increased percentage yield of ventricular derivatives
and cannot be ruled out, although miR overexpression led to
neither cytoxicity nor functional changes of atrial CMs. Further-
more, up-regulated gene expression and/or hypertrophy (without
hyperplasia) can lead to some of the results presented (e.g.,
upregulation of MHC). While our data did not allow us to
distinguish between the possibilities, such would still support a pro-
ventricular effect.
Of note, we have not examined in this study other non-cardiac-
specific miRs such as the let-7 family that have also been identified
to display the same differential plateau expression pattern (e.g., in
fibroblasts) for their roles in terminal differentiation. It is possible
that these miRs play a more generalized role in maturation, which
in turn could lead to similar functional changes. Finally, no single
algorithm can make miR target predictions with 100% accuracy.
Indeed, some functionally defined targets (e.g., IRX5 [5], DLL1
[8], KCNE1 and IKNQ1 [44]) are not predicted by any of the
existing algorithms, suggesting that our target list is at best partial.
Based on our collective experimental and bioinformatic data
sets, we propose a sequence of biological events that occur during
human cardiac differentiation. This is schematically summarized
in Figure 7D. The first step requires the loss of pluripotency and
embryonic stemness that are mediated by miRs including the miR-
302 and -371/372/373 clusters. As cardiac differentiation
continues, ventricular specification occurs following cellular
changes in cell proliferation, size and apoptosis that are mediated
by miR-499. Subsequently, miR-1 regulates physiological hyper-
trophy and other changes in cell cycle and size, which in turn lead
to a series of well-orchestrated functional changes in electrophys-
iological, Ca
2+-handling and contractile properties for maturation.
Using hESCs as an experimental model, we have functionally
demonstrated that miRs play crucial and specific roles in human
Figure 7. Analysis of Putative Transcriptomic Effects of miR-1 and -499 Expression in CM Development and Maturation.
A) Transcriptomic analysis of predicted targets for miR-1 and -499 involved in select pathways as indicated. All genes were log2 transformed and
normalized. Cluster analysis was performed with Cluster 3.0 using centroid linkage. Pie charts for B) miR-1 and C) -499 summarizing the number of
genes (in parentheses) in each selected pathway or Gene Ontology (GO) classification that were found to agree with our transcriptomic data. See text
for further details. The color gradient corresponds to a percentage (%=number of genes in each group meeting criteria/total number of genes in
pathway or GO classification * 100). D) Summary of the proposed sequence of biological processes that occur during human cardiogenesis and the
actions of miR-1 and -499.
doi:10.1371/journal.pone.0027417.g007
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differentiation and maturation appear to cluster at specific
chromosomal locations. The effects of miRs on VCMs dynami-
cally depend on the developmental stages and are context-
dependent. We conclude that miR-1 and -499 play differential
roles in human cardiac differentiation: While miR-499 promotes
ventricular specification in the context of hESC-derived cardio-
vascular progenitors, miR-1 serves to facilitate their electrophys-
iological maturation.
Supporting Information
Figure S1 After LV-MLC2v-mCherry transduction, only
human fetal left ventricular (FLV) CMs but not HEK293
expressed mCherry fluorescence. Bars represent 50 mm.
(TIF)
Figure S2 The criteria to select miR-1, -133 and -499 for
further experiments.
(TIF)
Figure S3 Cell viability of control and transduced hE-
CMs assessed by a colorimetric MTT assay. No significant
differences were observed (p.0.05).
(TIF)
Figure S4 Representative AP tracings of Control, LV-
miR-1- and -miR-499-transduced hE-ACMs, and bar
graphs summarizing the AP parameters of the groups.
*p ,0.05.
(TIF)
Figure S5 Representative AP tracings of Control (n=7)
and LV-anti-miR-1-transduced (n=8) hE-VCMs, and bar
graphs summarizing the AP parameters of the groups.
*p ,0.05.
(TIF)
Figure S6 Representative tracings of Ca
2+ transients
recorded from control (n=6) and LV-anti-miR-1 trans-
duced hESC-CMs (n=12), and comparison of the
amplitude, maximum upstroke velocity (Vmax-upstroke,
U) and maximum decay velocity (Vmax-decay,D )o f
electrically-induced Ca
2+ transients of the two groups
as indicated.
(TIF)
Table S1 AP parameters for classification of CMs
subtypes.
(TIFF)
Table S2 Human ESC-derived cardiomyocytes (hESC-
CMs) action potential properties.
(TIFF)
Table S3 The primers were used to quantitatively
analysis gene expression.
(TIFF)
Table S4 Summary of the numbers of the correspond-
ing predicted targets of miR-1 or -499 in each of these
select pathways. The bracketed numbers indicate the number
of genes which expressed at low levels in hE-, hF- and hA-VCMs.
(TIFF)
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